Patent 7790145 was granted and assigned to Novartis on September, 2010 by the United States Patent and Trademark Office.
A respiratory dispersion is provided for the pulmonary delivery of at least two bioactive agents. The dispersion comprises a propellant suspension medium having dispersed therein a plurality of perforated microstructures, wherein the two bioactive agents are incorporated into individual perforated microstructures.